LM-108
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for LM-108, covering 2024-06-28 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C [Phase 1, Phase 2]